Aguettant Nordic ApS
Private limited companyCVR 40873309København SActive
Aguettant Nordic ApS is a private limited company, based in København S, active in wholesale of pharmaceutical goods and nursing supplies, founded in 2019. Equity grew to DKK 269k in 2026.
Key figures · financial year 2026
What has changed
calculated from recorded figures and datesFinancials: 2026 against 2025
- Gross profit rose 29% (2025 → 2026), to DKK 931k.
- Net profit rose 2% (2025 → 2026), to DKK 97,696.
- Equity rose 57% (2025 → 2026), to DKK 269k.
Management and owners, last 24 months
- New in management: Guillaume Jacques Marie D'arcy (ceo, 20/10/2025).
- Stepped down: Eric Rougemond (ceo, 01/10/2025).
Calculated from the latest two annual reports in sequence and from registrations in CVR. A figure that is missing in either year gives no line, and we derive no figures.
Financial statements
Financial years 2021–2026 · amounts in DKK thousandEquity and net profit
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | Change | |
|---|---|---|---|---|---|---|---|
| Revenue | not stated | not stated | not stated | not stated | not stated | not stated | – |
| Gross profit | 396 | 887 | 121 | 300 | 722 | 931 | +28.9% |
| Operating profit (EBIT) | −139 | 1 | −590 | −310 | 190 | 202 | +6.3% |
| Profit before tax | −144 | −25 | −637 | −420 | 96 | 98 | +1.6% |
| Net profit | −112 | −20 | −497 | −597 | 96 | 98 | +1.6% |
| Total assets | 1,038 | 1,916 | 2,208 | 1,662 | 1,903 | 1,977 | +3.9% |
| Equity | −62 | −82 | −579 | −1,175 | 171 | 269 | +57.2% |
| Liabilities | 1,100 | 1,998 | 2,787 | 2,837 | 1,732 | 1,708 | −1.4% |
| Cash and cash equivalents | 197 | 434 | 221 | 488 | 293 | 669 | +128.6% |
| Average number of employees | 3 | 4 | 3 | 3 | 0 | 0 | – |
Source: annual reports filed with the Danish Business Authority (XBRL). Figures for the company (not the group); change is the latest year against the year before. “–” means the figure is not stated in the annual report. Revenue is not stated for 2021, 2022, 2023, 2024, 2025, 2026: smaller companies may omit it, and we do not derive it from other figures.
Download the figures as CSV · free with an account, amounts in whole DKK
Annual reports
6 financial years| Financial year | Period | Published | Figures for | Documents |
|---|---|---|---|---|
| 2026 | 01/04/2025 – 31/03/2026 | 19/08/2026 | The company | PDF not statedXBRL |
| 2025 | 01/04/2024 – 31/03/2025 | 07/05/2026 | The company | PDF not statedXBRL |
| 2024 | 01/04/2023 – 31/03/2024 | 29/08/2024 | The company | PDFXBRL |
| 2023 | 01/04/2022 – 31/03/2023 | 12/06/2023 | The company | PDFXBRL |
| 2022 | 01/04/2021 – 31/03/2022 | 25/05/2022 | The company | PDFXBRL |
| 2021 | 17/10/2019 – 31/03/2021 | 31/05/2021 | The company | PDFXBRL |
The figures from all the annual reports are shown on this page. The documents themselves (PDF and XBRL, the machine-readable edition) are downloaded with a Pro account: sign in or create a free account, and then choose Pro. XBRL is the edition the figures on the page are read from.
Employees
monthly figures from CVRPosition in the industry
232 companies in the databaseComparison with the other companies in wholesale of pharmaceutical goods and nursing supplies based on the latest financial year.
Industry median: gross profit DKK 11.2m, net profit DKK 1.8m, equity DKK 9.6m, 9 employees.
Compared with similar companies
size, age and company form| Group | Gross profit | Equity |
|---|---|---|
| Companies with fewer than 20 employees69,967 companies in the comparison | No. 46,044of 69,742 Better than 34% | No. 48,184of 69,964 Better than 31% |
| Same industry and fewer than 20 employees150 companies in the comparison | No. 126of 150 Better than 16% | No. 128of 150 Better than 15% |
| Companies that are between 5 and 14 years old33,688 companies in the comparison | No. 23,900of 33,588 Better than 29% | No. 22,937of 33,687 Better than 32% |
| All companies of type ApS66,508 companies in the comparison | No. 44,337of 66,379 Better than 33% | No. 44,193of 66,505 Better than 34% |
The rank is calculated among companies in the database with a figure for the latest financial year, and is shown only for groups of at least ten companies.
Compare with the industry
Wholesale of pharmaceutical goods and nursing supplies- Aguettant Nordic ApSDKK 931k
- Ambu A/SDKK 3.6bn
- Stada Nordic ApSDKK 687m
- Aguettant Nordic ApSDKK 97,696
- Ambu A/SDKK 609m
- Stada Nordic ApSDKK 54.6m
- Aguettant Nordic ApSDKK 269k
- Ambu A/SDKK 6bn
- Stada Nordic ApSDKK 346.3m
- Aguettant Nordic ApS4
- Ambu A/S619
- Stada Nordic ApS51
Latest financial year per company. Choose up to three companies from the largest in the industry.
Owners and group
from the Public Ownership Register- Laboratoire Aguettant90%
Management
1 active registrationsExecutive management
| Name | Role | Appointed |
|---|---|---|
| Guillaume Jacques Marie D'arcy | CEO | 20/10/2025 |
- Founders
- Laboratoire Aguettant, Eric Rougemond
Former management (1)
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| Eric Rougemond | CEO | 17/10/2019 | 01/10/2025 |
Signing rule: Selskabet tegnes af en direktør.
Address and production units
1 active production unitsIslands Brygge 81E
2300 København S
| Production unit | Address | Employees | P number |
|---|---|---|---|
| AGUETTANT NORDIC ApS | Islands Brygge 81E, 4. tv, 2300 København S | 4 | 1025149447 |
Purpose
Selskabets formål er at udøve forretning med: Primært marketing såvel som import, indkøb og salg, eksport og alle andre kommercielle, finansielle og industrielle aktiviteter direkte eller indirekte relateret til lægemidler, medicinsk udstyr og kosmetik. Sekundært at beskæftige sig med køb, salg, overførsel, veksling og forvaltning af alle former for værdipapirer, aktier, obligationer, statsobligationer, fast ejendom og løsøre. Derudover enhver form for investering i eksisterende eller fremtidige industrielle-, kommercielle- og finansielle sektorer, fast ejendom eller i andre forpligtigelser i en sektor direkte eller indirekte relateret til selskabets aktiviteter både i Danmark og internationalt. Både for egen regning, på vegne af tredjeparter eller i samarbejde med tredjeparter. Selskabet kan generelt udføre enhver finansiel eller industriel drift relateret direkte eller indirekte til selskabets formål eller som vil muliggøre implementeringen af denne.
The purpose is quoted from the register in Danish.
Changes year by year
12 registered events20262 changesaccounts 2
- AccountsAnnual report for 2026 published
- AccountsAnnual report for 2025 published
20252 changesmanagement 2
- ManagementGuillaume Jacques Marie D'arcy appointed ceo
- ManagementEric Rougemond stepped down as ceo
20241 changeaccounts 1
- AccountsAnnual report for 2024 published
20231 changeaccounts 1
- AccountsAnnual report for 2023 published
20221 changeaccounts 1
- AccountsAnnual report for 2022 published
20211 changeaccounts 1
- AccountsAnnual report for 2021 published
20201 changeaddress 1
- AddressMoved to Islands Brygge 81E, 4. tv, 2300 København S
20193 changesfounded 1 · management 1 · ownership 1
- FoundedRegistered as AGUETTANT NORDIC ApS
- ManagementEric Rougemond appointed ceo
- OwnershipLaboratoire Aguettant registered as owner (90%)
Related companies
Same industry in København
- Nomeco A/S939 employees
- Abacus Medicine A/S388 employees
- Novo Nordisk Denmark A/S300 employees
- Msd Danmark ApS132 employees
- Astrazeneca A/S122 employees
- Sandoz A/S118 employees
Largest in the industry
- Ambu A/SDKK 3.6bn
- Stada Nordic ApSDKK 687m
- Nomeco A/SDKK 683m
- Orifarm Supply A/SDKK 538.5m
- Novo Nordisk Denmark A/SDKK 497.5m
- Sandoz A/SDKK 260.2m
Source and updates
The information comes from the Danish Central Business Register (Danish Business Authority) and from annual reports filed with the Danish Business Authority. Last synchronised 24/10/2026. The company is protected against advertising; contact details are not shown, and the data must not be used for marketing.